Thomsen LM. Patient safety in relation to biosimilars – how can we act as a patient organisation? EULAR 2017, OP0328-PARE.
Door corona dreigt wereldwijd tekort aan tocilizumab
sep 2021 | Arteriitis, Immuuntherapie, JIA, Lymfoom, RA, Virale infecties
nov 2022 | Psoriasis
nov 2020
okt 2020
aug 2020 | RA, SLE